Precipio Announces Christina Valauri joins the Board of Directors
NEW HAVEN, Conn., Jan. 02, 2024 (GLOBE NEWSWIRE) — Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) is pleased to welcome Christina Valauri to its board of directors effective Jan 1st, 2024. Ms. Valauri is joining Precipio’s board to support management’s understanding of and interaction with the capital markets, as we look towards 2024 to be an important period for our company from both a business growth, and financial perspective.
Related news for (PRPO)
- Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting
- Precipio Announces Q1-2025 Shareholder Update Call
- Precipio Announces Q4 and year-end 2024 Shareholder Update Call
- Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited)
- Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs
